Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:alsoKnownAs |
PF-00835231
|
| gptkbp:CASNumber |
2384169-07-6
|
| gptkbp:chemicalFormula |
C23H32N4O5S
|
| gptkbp:clinicalTrialPhase |
preclinical
|
| gptkbp:developedBy |
gptkb:Pfizer
|
| gptkbp:function |
3CL protease inhibitor
|
| https://www.w3.org/2000/01/rdf-schema#label |
OMC-19
|
| gptkbp:intendedUse |
antiviral drug
|
| gptkbp:relatedTo |
COVID-19 treatment research
|
| gptkbp:target |
gptkb:SARS-CoV-2_main_protease
|
| gptkbp:bfsParent |
gptkb:Orion_Nebula_complex
|
| gptkbp:bfsLayer |
7
|